Abstract:Background The pathogenesis of post-stroke depression (PSD) remains largely unknown. There is growing evidence indicating that gut microbiota participates in the development of brain diseases through the gut-brain axis. Here, we aim to determine whether and how microbial composition and function altered among control, stroke and PSD rats. Materials and Methods After the PSD rat model was successfully established, gut microbiome combined with fecal metabolome approach were performed to identify potentially PSD-related gut microbes and their functional metabolites. Then, correlations between behavior indices and altered gut microbes, as well as correlations between altered gut microbial operational taxonomic units (OTUs) with differential metabolites in PSD rats were explored. Enrichment analysis was also conducted to uncover the crucial metabolic pathways related to PSD. Results Although there were some alterations in the microbiome and metabolism of the control and stroke rats, we found that the microbial and metabolic phenotypes of PSD rats were significantly different. The microbial composition of PSD showed a decreased species richness indices, characterized by 22 depleted OTUs mainly belonging to phylum Firmicutes , genus Blautia and Streptococcus . In addition, PSD was associated with disturbances of fecal metabolomics, among them Glutamate, Maleic acid, 5-Methyluridine, Gallocatechin, 1,5-Anhydroglucitol, L-Kynurenine, Daidzein, Cyanoalanine, Acetyl Alanine and 5-Methoxytryptamine were significantly related to disturbed gut microbiome (P ≤ 0.01). Disordered fecal metabolomics in PSD rats mainly assigned to lipid, amino acid, carbohydrate and nucleotide metabolism. The steroid biosynthesis was particularly enriched in PSD. Conclusions Our findings suggest that gut microbiome may participate in the development of PSD, the mechanism may be related to the regulation of lipid metabolism.

Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

Pathological Mechanism and Drug Therapy for Post Stroke Depression

Effect of Inflammation on the Process of Stroke Rehabilitation and Poststroke Depression

Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression

Neural Substrates of Poststroke Depression: Current Opinions and Methodology Trends

Exploring the pathogenesis and treatment of PSD from the perspective of gut microbiota

Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression: A literature review

Understanding Why Post-Stroke Depression May Be the Norm Rather Than the Exception: The Anatomical and Neuroinflammatory Correlates of Post-Stroke Depression

Role and characteristics of hippocampal region microglial activation in poststroke depression

The Relationship of Astrocytes and Microglia with Different Stages of Ischemic Stroke.

Post-stroke depression: A 2020 updated review

Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression

Advancing Post-Stroke Depression Research: Insights from Murine Models and Behavioral Analyses

Review on stroke induced depression

Glutamate Dysfunctional Etiology Hypothesis of Post-stroke Depression

The Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery

Regulation of microglia polarization after cerebral ischemia

Cell polarization in ischemic stroke: molecular mechanisms and advances

Microglia Autophagy in Ischemic Stroke: A Double-Edged Sword

Natural Products for the Treatment of Post-stroke Depression